Review of the Evidence for Treatment of Children with Autism with Selective Serotonin Reuptake Inhibitors

被引：29

作者：

West, Lis ^{[2
]}

Brunssen, Susan H. ^{[1
]}

Waldrop, Julee ^{[1
]}

机构：

[1] Univ N Carolina, Sch Nursing, Chapel Hill, NC 27515 USA

[2] Carolina Pediat Grp, Fayetteville, NC USA

来源：

JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING | 2009年 / 14卷 / 03期

关键词：

Antidepressants; autism; pervasive developmental disorder; pharmacotherapy; psychopharmacotherapy; selective serotonin reuptake inhibitors; PERVASIVE DEVELOPMENTAL DISORDERS; PHARMACOLOGICAL-TREATMENT; OPEN-LABEL; ADOLESCENTS; TRANSPORTER; FLUOXETINE; SYMPTOMS; PATTERNS; HYPERACTIVITY; FLUVOXAMINE;

D O I：

10.1111/j.1744-6155.2009.00196.x

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

PURPOSE. To review the potential role of serotonin dysregulation in autism and the efficacy of selective serotonin reuptake inhibitors (SSRIs) in treating core deficits and associated symptoms of autism in children. The literature was searched for reports of SSRI use in children with autism. Data are presented from prospective clinical trials that evaluated treatment outcomes. CONCLUSIONS. Some SSRIs show moderate success in managing specific behaviors. Only fluoxetine shows evidence of decreasing global autism severity. PRACTICE IMPLICATION. Definitive conclusions concerning selection criteria, dosage, safety, and efficacy cannot be drawn given the current state of evidence.

引用

页码：183 / 191

页数：9

共 50 条

[1] Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors (vol 14, pg 183, 2009)
West
Brunssen
Waldrop
JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING, 2009, 14 (04) : 301 - 302
[2] Selective Serotonin Reuptake Inhibitors and Autism
Walch, Tina J.
Tinkelman, Amanda
AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (02) : E325 - E325
[3] Selective serotonin reuptake inhibitors in autism: A review of efficacy and tolerability
Kolevzon, A
Mathewson, KA
Hollander, E
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (03) : 407 - 414
[4] Selective serotonin reuptake inhibitors in pediatric psychopharmacology: A review of the evidence
Hammerness, PG
Vivas, FM
Geller, DA
JOURNAL OF PEDIATRICS, 2006, 148 (02): : 158 - 165
[5] Selective serotonin reuptake inhibitors and violence: a review of the available evidence
Walsh, MT
Dinan, TG
ACTA PSYCHIATRICA SCANDINAVICA, 2001, 104 (02) : 84 - 91
[6] The selective serotonin reuptake inhibitors controversy in the treatment of depression in children
Weller E.B.
Tucker S.
Weller R.A.
Current Psychiatry Reports, 2005, 7 (2) : 87 - 90
[7] Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression in Children and AdolescentsPractitioner Review
Susan C. Sharp
Jessica A. Hellings
Clinical Drug Investigation, 2006, 26 : 247 - 255
[8] Making a Case to Continue Considering Treatment with Selective Serotonin Reuptake Inhibitors for Children with Autism Spectrum Disorders
Wendy Froehlich
Current Psychiatry Reports, 2011, 13
[9] Making a Case to Continue Considering Treatment with Selective Serotonin Reuptake Inhibitors for Children with Autism Spectrum Disorders
Froehlich, Wendy
CURRENT PSYCHIATRY REPORTS, 2011, 13 (03) : 170 - 173
[10] Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence
Alwan, Sura
Friedman, Jan M.
Chambers, Christina
CNS DRUGS, 2016, 30 (06) : 499 - 515

← 1 2 3 4 5 →